Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Clonal anergy
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Molecular mechanism of anergy induction in T lymphocytes== Understanding the molecular mechanism of anergy induction in [[T cell|T lymphocytes]] unveils the intricate interplay of signaling pathways governing immune responses. Upon stimulation, the [[T cell receptor]] (TCR) in conjunction with co-stimulatory receptors orchestrates a comprehensive activation of all the [[T cell|T-cell]]’s signaling pathways, collectively termed full T-cell stimulation. Among these pathways, the calcium-dependent arm of lymphocyte signaling is particularly pivotal, triggered by [[T cell receptor|TCR]] engagement. This initiates a cascade culminating in an elevation of intracellular [[Calcium|Ca<sup>+II</sup>]] concentration,<ref name="Macián et al">{{cite journal |vauthors=Macián F, García-Cózar F, Im SH, Horton HF, Byrne MC, Rao A |date=June 2002 |title=Transcriptional mechanisms underlying lymphocyte tolerance |journal=Cell |volume=109 |issue=6 |pages=719–731 |doi=10.1016/S0092-8674(02)00767-5 |pmid=12086671 |doi-access=free}}</ref> a critical event in T cell activation. Under such conditions, the calcium-dependent phosphatase [[calcineurin]] acts on the [[transcription factor]] [[NFAT]], facilitating its translocation to the nucleus, where it regulates gene expression. Expanding upon this complexity, during full [[T cell|T-cell]] stimulation the [[Co-stimulation|co-stimulatory]] receptor [[CD28]] activates [[Phosphoinositide 3-kinase|PI3K]] and other pathways, augmenting the nuclear levels of key transcription factors such as [[REL|rel]], [[NF-kappaB|NF-κB]] and [[AP-1 transcription factor|AP-1]] beyond those induced by TCR activation alone.<ref name="Macián et al" /> The formation of [[AP-1 transcription factor|AP-1]], [[C-Fos|fos]]/[[C-jun|jun]] heterodimer, further complexes with [[NFAT]], creating a transcriptional complex crucial for the expression of genes<ref name="Rudensky et al">{{cite journal |vauthors=Rudensky AY, Gavin M, Zheng Y |date=July 2006 |title=FOXP3 and NFAT: partners in tolerance |journal=Cell |volume=126 |issue=2 |pages=253–256 |doi=10.1016/j.cell.2006.07.005 |pmid=16873058 |doi-access=free}}</ref> associated with [[T cell|T-cell]] productive responses, including [[Interleukin 2|IL-2]] and its [[IL-2 receptor|receptor]].<ref name="Rudensky et al" /> In contrast, [[T cell receptor|TCR]] signaling in the absence of co-stimulatory receptors predominantly activates the calcium arm of the signaling pathway, leading to [[NFAT]] activation alone. However, without the concurrent induction of [[AP-1 transcription factor|AP-1]] by other pathways, [[NFAT]] fails to form the transcriptional complex necessary for a productive [[T cell|T-cell]] response. Instead, [[NFAT]] homodimerizes, functioning as a transcriptional factor that induces anergy in the lymphocyte.<ref name="Soto-Nieves et al">{{cite journal |vauthors=Soto-Nieves N, Puga I, Abe BT, Bandyopadhyay S, Baine I, Rao A, Macian F |date=April 2009 |title=Transcriptional complexes formed by NFAT dimers regulate the induction of T cell tolerance |journal=The Journal of Experimental Medicine |volume=206 |issue=4 |pages=867–876 |doi=10.1084/jem.20082731 |pmc=2715123 |pmid=19307325}}</ref> [[NFAT]] homodimers play a direct role in the expression of anergy-associated genes, such as the ubiquitin ligase [[RNF128|GRAIL]] and the protease [[caspase 3]].<ref name="Soto-Nieves et al" /> Furthermore, anergized cells exhibit decreased expression levels of [[Interleukin 2|IL-2]], [[Tumor necrosis factor alpha|TNFα]], and [[Interferon gamma|IFNγ]], characteristic of a productive response, while favoring the production of the anti-inflammatory cytokine [[Interleukin 10|IL-10]].<ref name="Macián et al" /> Although three [[NFAT]] proteins - NFAT1, NFAT2 and NFAT4 - are preset in T-cells, they demonstrate redundancy to some extent.<ref name="Soto-Nieves et al" /> In the context of antigen presentation by [[Antigen-presenting cell|antigen-presenting cells]] (APC), [[T cell|T lymphocytes]] undergo a productive response when the antigen is appropriately presented, activating T cell co-stimulatory receptors. However, encountering antigens not presented by the [[Antigen-presenting cell|APCs]] or weakly presented antigens induces anergic responses in T cells.<ref name="Soto-Nieves et al" /> Notably, strong stimulation through [[Interleukin 2|IL-2]] or [[T cell receptor|TCR]]/co-stimulatory receptors can overcome anergy, highlighting the dynamic nature of immune regulation.<ref name="Macián et al" /><ref name="Rudensky et al" /> Moreover, recent research has illuminated the role of regulatory T cells (Tregs) in modulating T cell responses and maintaining immune tolerance. Tregs, characterized by the expression of the transcription factor Foxp3, exert immunosuppressive effects by inhibiting the activation and function of effector T cells.<ref name="Soto-Nieves et al" /> Importantly, Tregs can directly interact with anergic T cells, further reinforcing their state of unresponsiveness and promoting peripheral tolerance. This interaction involves various mechanisms, including the secretion of inhibitory cytokines such as IL-10 and TGF-β, as well as cell-contact-dependent suppression mediated by molecules like CTLA-4.<ref name="Macián et al" /> Understanding the intricate crosstalk between Tregs and anergic T cells provides valuable insights into the maintenance of immune homeostasis and has implications for therapeutic strategies aimed at modulating immune responses in autoimmune diseases and transplantation.<ref name="Rudensky et al" /><ref name="Soto-Nieves et al" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)